ASND
Ascendis Pharma AS
NASDAQ: ASND · HEALTHCARE · BIOTECHNOLOGY
$220.28
-0.81% today
Updated 2026-04-29
Market cap
$13.61B
P/E ratio
—
P/S ratio
18.90x
EPS (TTM)
$-4.40
Dividend yield
—
52W range
$151 – $251
Volume
0.7M
Ascendis Pharma AS (ASND) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $22.82M | $25.41M | $26.70M | $58.67M | $131.77M | $190.07M | $210.98M | $318.97M | $676.73M | $979.79M | $1.08B | $1.09B | $825.59M | $1.18B |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | $17.97M | $20.70M | $21.20M | $53.16M | $125.65M | $183.96M | $204.63M | $292.91M | $611.17M | $740.13M | $805.89M | $923.47M | $702.72M | $1.06B |
| Total liabilities | $22.59M | $23.85M | $20.40M | $12.86M | $11.45M | $13.46M | $23.77M | $38.92M | $79.62M | $141.08M | $201.29M | $826.39M | $971.28M | $1.29B |
| Current liabilities | $22.37M | $23.85M | $20.40M | $12.86M | $11.45M | $13.46M | $23.77M | $38.92M | $47.99M | $52.80M | $100.36M | $716.78M | $736.51M | $907.86M |
| Long-term debt | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | $97.97M | $482.96M | $534.25M | $365.08M |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $-3.19M | $-1.95M | $2.13M | $39.56M | $111.28M | $-139.31M | $-263.21M | $-393.31M | $-611.32M | $-1.03B | $-1.24B | $-1.86B | $-2.28B | $-2.56B |
| Accounts receivable | $2.02M | $5.72M | $1.71M | $1.29M | $1.06M | $287000.00 | $188000.00 | $6000.00 | $804000.00 | $387000.00 | $2.20M | $11.91M | $35.87M | $166.28M |
| Inventory | — | — | — | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | $-3.00 | $1.00 | $75.41M | $130.67M | $208.93M | $295.61M |
| Goodwill | $3.50M | $3.50M | $3.50M | $3.50M | $3.50M | $3.50M | $3.50M | $3.50M | $3.50M | $3.50M | $3.50M | $3.50M | $3.50M | $3.50M |